JP2019509748A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019509748A5 JP2019509748A5 JP2018550831A JP2018550831A JP2019509748A5 JP 2019509748 A5 JP2019509748 A5 JP 2019509748A5 JP 2018550831 A JP2018550831 A JP 2018550831A JP 2018550831 A JP2018550831 A JP 2018550831A JP 2019509748 A5 JP2019509748 A5 JP 2019509748A5
- Authority
- JP
- Japan
- Prior art keywords
- factor
- fine
- nucleic acid
- heterologous nucleic
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022070121A JP2022101642A (ja) | 2016-03-30 | 2022-04-21 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
| JP2025019374A JP2025087704A (ja) | 2016-03-30 | 2025-02-07 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662315480P | 2016-03-30 | 2016-03-30 | |
| US62/315,480 | 2016-03-30 | ||
| PCT/US2017/024951 WO2017173043A1 (en) | 2016-03-30 | 2017-03-30 | Cell line for recombinant protein and/or viral vector production |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022070121A Division JP2022101642A (ja) | 2016-03-30 | 2022-04-21 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019509748A JP2019509748A (ja) | 2019-04-11 |
| JP2019509748A5 true JP2019509748A5 (enExample) | 2020-04-09 |
Family
ID=59966430
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018550831A Withdrawn JP2019509748A (ja) | 2016-03-30 | 2017-03-30 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
| JP2022070121A Pending JP2022101642A (ja) | 2016-03-30 | 2022-04-21 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
| JP2025019374A Pending JP2025087704A (ja) | 2016-03-30 | 2025-02-07 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022070121A Pending JP2022101642A (ja) | 2016-03-30 | 2022-04-21 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
| JP2025019374A Pending JP2025087704A (ja) | 2016-03-30 | 2025-02-07 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20190078099A1 (enExample) |
| EP (1) | EP3436576A4 (enExample) |
| JP (3) | JP2019509748A (enExample) |
| KR (1) | KR102479894B1 (enExample) |
| CN (1) | CN109563496B (enExample) |
| AU (2) | AU2017244133A1 (enExample) |
| BR (1) | BR112018070250A2 (enExample) |
| CA (1) | CA3019126A1 (enExample) |
| MX (1) | MX2018011928A (enExample) |
| SG (1) | SG11201808398PA (enExample) |
| WO (1) | WO2017173043A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107106689A (zh) | 2014-11-05 | 2017-08-29 | 沃雅戈治疗公司 | 用于治疗帕金森病的aadc多核苷酸 |
| CN112410338A (zh) | 2014-11-14 | 2021-02-26 | 沃雅戈治疗公司 | 调节性多核苷酸 |
| IL292999A (en) | 2014-11-14 | 2022-07-01 | Voyager Therapeutics Inc | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
| WO2016094783A1 (en) | 2014-12-12 | 2016-06-16 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scaav |
| SG11201809699XA (en) | 2016-05-18 | 2018-12-28 | Voyager Therapeutics Inc | Modulatory polynucleotides |
| US12359184B2 (en) | 2017-05-24 | 2025-07-15 | Thoeris Gmbh | Use of glutamine synthetase for treating hyperammonemia |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| WO2018237170A1 (en) * | 2017-06-21 | 2018-12-27 | Bertram Timothy A | BIOACTIVE IMMUNO-PRIVILEGE RENAL CELLS FOR THE TREATMENT OF RENAL DISEASE |
| IL321310A (en) | 2017-10-20 | 2025-08-01 | Res Inst Nationwide Childrens Hospital | Methods and materials for NT-3 gene therapy |
| EP3794126A1 (en) | 2018-05-15 | 2021-03-24 | Voyager Therapeutics, Inc. | Compositions and methods for the treatment of parkinson's disease |
| WO2020012446A1 (en) * | 2018-07-13 | 2020-01-16 | Enzene Biosciences Limited | Double knock-out cho cell line method of its generation and producing therapeutic proteins therefrom |
| CN113383010B (zh) | 2018-09-28 | 2025-09-09 | 沃雅戈治疗公司 | 具有经工程化改造的启动子的共济蛋白表达构建体及其使用方法 |
| KR20210082460A (ko) * | 2018-10-01 | 2021-07-05 | 울트라제닉스 파마수티컬 인코포레이티드 | 프로피온산혈증을 치료하기 위한 유전자 요법 |
| JP2023536148A (ja) | 2020-07-30 | 2023-08-23 | シェイプ セラピューティクス インク． | Ｒａａｖウイルス粒子の誘導産生のための安定な細胞株 |
| WO2022138869A1 (ja) * | 2020-12-25 | 2022-06-30 | Ａｇｃ株式会社 | ベクター産生能力が向上したウイルスベクター産生細胞及びその製造方法及びその選択方法 |
| WO2022187546A1 (en) | 2021-03-03 | 2022-09-09 | Shape Therapeutics Inc. | Auxotrophic cells for virus production and compositions and methods of making |
| US12234472B2 (en) | 2021-10-18 | 2025-02-25 | Regeneron Pharmaceuticals, Inc. | Eukaryotic cells comprising adenovirus-associated virus polynucleotides |
| EP4473123A4 (en) * | 2022-02-01 | 2026-03-11 | Shape Therapeutics Inc | STABLE CELL LINES FOR INDUCIBLE VAAR VIRION PRODUCTION |
| EP4514470A1 (en) | 2022-04-29 | 2025-03-05 | Broadwing Bio LLC | Angiopoietin-related protein 7-specific antibodies and uses thereof |
| KR20250021400A (ko) | 2022-04-29 | 2025-02-12 | 브로드윙 바이오 엘엘씨 | 보체 인자 h 관련 4-특이적 항체 및 그의 용도 |
| EP4514845A1 (en) | 2022-04-29 | 2025-03-05 | Broadwing Bio LLC | Bispecific antibodies and methods of treating ocular disease |
| WO2024227154A1 (en) | 2023-04-28 | 2024-10-31 | Broadwing Bio Llc | Complement component 3 (c3)-specific antibodies and uses thereof |
| WO2025128343A1 (en) | 2023-12-11 | 2025-06-19 | Just-Evotec Biologics, Inc. | Protein expression using trans-splicing and split selectable markers |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080001001A1 (en) * | 2006-04-17 | 2008-01-03 | Pevnick Stephen H | Pneumatic Activated Fountain |
| WO2007136685A2 (en) * | 2006-05-19 | 2007-11-29 | Sangamo Biosciences, Inc. | Methods and compositions for inactivation of dihydrofolate reductase |
| CN102264915B (zh) * | 2008-10-29 | 2014-04-16 | 桑格摩生物科学股份有限公司 | 失活谷氨酰胺合成酶基因表达的方法和组合物 |
| AU2015201300A1 (en) * | 2008-10-29 | 2015-04-02 | Sangamo Therapeutics, Inc. | Methods and Compositions For Inactivating Glutamine Synthetase Gene Expression |
| ES2713529T3 (es) * | 2011-06-01 | 2019-05-22 | Prec Biosciences Inc | Procedimientos y productos para la producción de líneas celulares de mamífero modificadas con transgenes amplificados |
| KR102057540B1 (ko) * | 2012-02-17 | 2019-12-19 | 더 칠드런스 호스피탈 오브 필라델피아 | 세포, 기관 및 조직으로의 유전자 전이를 위한 ａａｖ 벡터 조성물 및 방법 |
| MX364690B (es) * | 2013-03-15 | 2019-05-06 | Childrens Hospital Philadelphia | Proceso de elaboracion escalable para producir vectores lentivirales recombinantes en un sistema de cultivo celular en suspension libre de suero. |
| PT3024498T (pt) * | 2013-07-22 | 2020-03-06 | Childrens Hospital Philadelphia | Variante aav e composições, métodos e usos para transferência genética em células, órgãos e tecidos |
| KR20170081784A (ko) * | 2016-01-04 | 2017-07-13 | 한국과학기술원 | Gs 유전자가 결핍된 신규한 hek293 세포주 및 상기 형질전환된 hek293 숙주세포를 이용한 목적 단백질의 생산 방법 |
-
2017
- 2017-03-30 CA CA3019126A patent/CA3019126A1/en active Pending
- 2017-03-30 US US16/088,693 patent/US20190078099A1/en active Pending
- 2017-03-30 JP JP2018550831A patent/JP2019509748A/ja not_active Withdrawn
- 2017-03-30 KR KR1020187031368A patent/KR102479894B1/ko active Active
- 2017-03-30 AU AU2017244133A patent/AU2017244133A1/en not_active Abandoned
- 2017-03-30 WO PCT/US2017/024951 patent/WO2017173043A1/en not_active Ceased
- 2017-03-30 EP EP17776630.0A patent/EP3436576A4/en active Pending
- 2017-03-30 MX MX2018011928A patent/MX2018011928A/es unknown
- 2017-03-30 CN CN201780022183.9A patent/CN109563496B/zh active Active
- 2017-03-30 SG SG11201808398PA patent/SG11201808398PA/en unknown
- 2017-03-30 BR BR112018070250A patent/BR112018070250A2/pt not_active Application Discontinuation
-
2022
- 2022-04-21 JP JP2022070121A patent/JP2022101642A/ja active Pending
-
2023
- 2023-06-26 AU AU2023204029A patent/AU2023204029B2/en active Active
-
2025
- 2025-02-07 JP JP2025019374A patent/JP2025087704A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016185153A5 (enExample) | ||
| AU2023204029B2 (en) | Cell line for recombinant protein and/or viral vector production | |
| FI3517134T3 (fi) | Adeno-assosioituneen viruksen (aav) serotyypin 8 sekvenssejä, niitä sisältäviä vektoreita ja niiden käyttöjä | |
| JP2018121653A5 (enExample) | ||
| FI3488007T3 (fi) | Skaalautuvia korkeasaantoisia menetelmiä adeno-assosioidun rekombinanttiviruksen (rAAV) vektorin tuottamiseksi korkealla saannolla ja siten tuotettuja adeno-assosioidun rekombinanttiviruksen (rAAV) vektoreita | |
| JP2024073614A (ja) | プラスミドを用いないａａｖベクター産生細胞株 | |
| Backliwal et al. | High‐density transfection with HEK‐293 cells allows doubling of transient titers and removes need for a priori DNA complex formation with PEI | |
| CN105283553B (zh) | 蛋白质富集的微泡及其制备和使用方法 | |
| US7056502B2 (en) | Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids | |
| TWI478937B (zh) | 改良之哺乳動物表現載體及其用途 | |
| JP2022097744A (ja) | 緩衝剤溶液を提供するための方法及びシステム | |
| CN104781389B (zh) | 蛋白质生产促进剂 | |
| CN113631711A (zh) | 核酸的靶向整合 | |
| US20190093126A1 (en) | Large commercial scale lentiviral vector production system and vectors produced thereby | |
| NZ747127B2 (en) | Cell line for recombinant protein and/or viral vector production | |
| EP4578952A1 (en) | Method for introducing nucleic acid into cells and application thereof | |
| WO2022261475A1 (en) | Methods of regulating adeno-associated virus production | |
| Mistry | Thermoresponsive Elastin-like Polypeptide Triblock for Cell Encapsulation and 3D Bioprinting Applications | |
| CN121443633A (zh) | 掺入驱动可选择标记表达的启动子组合的载体 | |
| US20250188447A1 (en) | Modular vector (modvec) system: a platform for construction of next generation expression vectors | |
| CN120435566A (zh) | 用于产生腺相关病毒的微链dna | |
| CN117897401A (zh) | 平台宿主对igf-培养基的适应 | |
| DePalma | Optimizing Cell Lines Improves Production—Really! | |
| HK40041212A (en) | Targeted integration of nucleic acids | |
| RU2016152555A (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pBiPr-ABIgA2m1F16-ht ДЛЯ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО ИММУНОГЛОБУЛИНА А ИЗОТИПА IGA2m1 |